Synthesis of N 2-Arylisocytidines and N 2-Aryl-2′-deoxyisocytidines |
| |
Authors: | Omar M Ali |
| |
Institution: | (1) Department of Applied Bio-organic Chemistry, Gifu University, Gifu 501-1193, Japan;(2) Department of Food Science, Gifu University, Gifu 501-1193, Japan;(3) CREST, Japan Science and Technology Agency (JST), Tokyo, Japan;(4) Department of Neurology and Research Institute for Neuroimmunological Diseases, Dokkyo Medical University School of Medicine, Kitakobayashi 880, Mibu, Shimotsuga, Tochigi 321-0293, Japan; |
| |
Abstract: | 2-(Arylamino)pyrimidin-4-ones were synthesized, silylated, and condensed with l,2,3,5-tetra-O-acetyl-β- d-ribofuranoside to afford the corresponding N
2-aryl protected isocytidines. Deprotection of the acetylated isocytidines using saturated NH3 in MeOH solution gave 1-(β-d-ribofuranosyl)-2-(arylamino)-4-pyrimidinones. Methyl 2-deoxy-3,5-di-O-toluyl-α/β-d-ribofuranoside was prepared and condensed with the previously silylated bases to afford the anomeric mixture of protected
nucleosides. The pure β-anomers were synthesized with better yield by treating the sodium salts of N
2-arylisocytosine derivatives with 2-deoxy-3,5-di-O-toluyl-α-d-ribofuranosyl chloride. Deprotection of the latter anomers afforded the corresponding free hydroxyl derivatives. The synthesized
free nucleosides are under antiviral and oligonucleotide investigations. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|